About Technology Issues FAQ

Links

Official Page

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA^®)

Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA<sup>®</sup>) — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.